US Broker Ratings

Sonida Senior Living, Inc. (SNDA) Stock Analysis: Navigating Growth Amidst Challenging Valuations

Sonida Senior Living, Inc. (SNDA) stands as a notable player within the healthcare sector, specifically focusing on medical care facilities in the United States. With a current market capitalization of..

LifeMD, Inc. (LFMD) Stock Analysis: Discovering a Potential 233.94% Upside in the Telehealth Revolution

LifeMD, Inc. (NASDAQ: LFMD) is making waves in the healthcare sector as a direct-to-patient telehealth provider poised for significant growth. With its market cap standing at $133.34 million, LifeMD operates..

Upstream Bio, Inc. (UPB) Stock Analysis: Exploring an 83% Potential Upside in Biotech Innovation

Upstream Bio, Inc. (NASDAQ: UPB) has captured the attention of investors within the biotechnology sector, primarily due to its promising pipeline and significant potential upside. As a clinical-stage biotechnology company,..

AMN Healthcare Services Inc (AMN) Stock Analysis: Navigating Challenges and Opportunities in Healthcare Staffing

AMN Healthcare Services Inc (AMN) is a prominent player in the U.S. medical care facilities industry, providing a range of workforce solutions and staffing services to healthcare institutions. With a..

Xencor, Inc. (XNCR) Stock Report: Analysts Predict 166% Upside Potential

Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company, is making waves in the healthcare sector with its robust pipeline of engineered monoclonal antibodies. As Xencor focuses on treating a variety..

Geron Corporation (GERN) Stock Analysis: Uncovering a 132.88% Potential Upside in Biotech

For investors with an appetite for high-risk and high-reward opportunities, Geron Corporation (NASDAQ: GERN) presents an intriguing case within the biotechnology sector. With its focus on oncology therapeutics, Geron is..

Ginkgo Bioworks Holdings, Inc. (DNA) Investor Outlook: Understanding the 20% Potential Upside Amidst Challenges

Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) stands at the intersection of biotechnology and innovation, offering investors a glimpse into the future of cell programming. Despite a challenging market environment, the..

Kura Oncology, Inc. (KURA): Growth Potential with a 338.58% Upside and Strong Buy Ratings

Kura Oncology, Inc. (NASDAQ: KURA) stands out in the biotech sector with its promising drug pipeline aimed at tackling some of the most challenging oncological diseases. As a clinical-stage biopharmaceutical..

Embecta Corp. (EMBC) Stock Analysis: Navigating a 59% Potential Upside Amid Healthcare Innovations

Embecta Corp. (NASDAQ: EMBC), a prominent player in the healthcare sector, specifically within the Medical Instruments & Supplies industry, is poised for an intriguing journey. With its headquarters in Parsippany,..

Collegium Pharmaceutical, Inc. (COLL) Stock Analysis: A 13.31% Upside with Strong Buy Ratings

Collegium Pharmaceutical, Inc. (NASDAQ: COLL), a key player in the specialty pharmaceutical sector, focuses on developing and commercializing innovative pain management solutions. With a market capitalization of $1.48 billion, it..

ArriVent BioPharma, Inc. (AVBP) Stock Analysis: Exploring an 88.45% Potential Upside

ArriVent BioPharma, Inc. (NASDAQ: AVBP) is emerging as a compelling player in the biotechnology sector, capturing the attention of investors with its promising pipeline and significant market potential. With a..

Theravance Biopharma Inc. (TBPH) Stock Analysis: Unveiling a 36% Potential Upside

Theravance Biopharma, Inc. (NASDAQ: TBPH) stands out in the biotechnology sector with its promising product pipeline and strategic collaborations. With a market capitalization of $992.17 million, Theravance is a key..

iRadimed Corporation (IRMD): Investor Outlook Reveals Nearly 5% Upside Potential

iRadimed Corporation (NASDAQ: IRMD) has been making waves in the healthcare sector, particularly within the medical devices industry. With a market capitalization of $1.2 billion, the U.S.-based company is a..

Relay Therapeutics, Inc. (RLAY) Stock Analysis: Unpacking a 78% Potential Upside Amid Healthcare Innovations

Investors keen on the healthcare sector might find Relay Therapeutics, Inc. (NASDAQ: RLAY) a compelling story, given its significant potential upside and innovative approach in biotechnology. With a market capitalization..

Niagen Bioscience, Inc. (NAGE) Stock Analysis: A Healthcare Star with a 208% Potential Upside

Niagen Bioscience, Inc. (NAGE), a prominent player in the biotechnology sector, is attracting significant attention with its compelling investment potential. Headquartered in Los Angeles, California, Niagen is dedicated to developing..

Enhabit, Inc. (EHAB) Stock Analysis: Unlocking a 6.62% Potential Upside in the Healthcare Sector

Enhabit, Inc. (EHAB), a significant player in the healthcare sector, has caught the attention of investors looking to capitalize on the growing demand for medical care facilities. With a current..

Enliven Therapeutics, Inc. (ELVN): Investor Outlook with a 53.3% Potential Upside and Strong Buy Ratings

Enliven Therapeutics, Inc. (NASDAQ: ELVN) is capturing the attention of savvy investors in the biotechnology sector. With a market capitalization of $1.6 billion, this clinical-stage biopharmaceutical company is making waves..

Zymeworks Inc. (ZYME) Stock Analysis: Biotech’s 61.74% Upside Potential Amid Robust Revenue Growth

Investors eyeing opportunities in the biotechnology sector should take a closer look at Zymeworks Inc. (NASDAQ: ZYME), a clinical-stage company making strides in the realm of cancer and autoimmune disease..

Sana Biotechnology, Inc. (SANA) Stock Analysis: A 145% Upside Amidst Innovative Biotech Ventures

Sana Biotechnology, Inc. (NASDAQ: SANA) is capturing significant interest in the biotechnology sector, with a compelling potential upside of 145.47% based on current analyst targets. This Seattle-based company is carving..

Orthofix Medical Inc. (OFIX) Investor Outlook: Analyzing a Potential 53% Upside in the Medical Device Sector

Orthofix Medical Inc. (NASDAQ: OFIX), a prominent player in the healthcare sector specializing in medical devices, presents a compelling case for investors seeking opportunities in a challenging market. With a..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds